Capital Markets
Clients need the highest quality service in an ever-evolving legal and regulatory environment. Our team has genuine sector expertise, meaning we can respond to the specific needs and character of clients in a wide variety of sectors.
Transactions often involve a cross-border element, which requires a co-ordinated and unified approach from our international network of offices. Our advice covers the full range of equity financing transactions including initial public offerings on key international exchanges (including London, Australia, Hong Kong and Singapore), rights issues, placings and other secondary offerings, capital reorganisations, reverse takeovers and public takeovers and mergers.
We routinely act for issuers, investment banks and underwriters, bookrunners, sponsors, nominated advisers, management teams and shareholders on a wide range of equity market transactions.
Latest insights
More Insights.jpg?h=335&iar=0&w=500&hash=89A248F17EC1DDD6C2CD77D7011BB4CF)
Meet the Capital Markets team
See the full team
International Capital Markets Deal Round Up H1 2024 International Capital Markets Annual Review 2023
International Capital Markets H1 2023 International Capital Markets Annual Review 2022
Deal Highlights International Capital Markets Annual review 2021
International Capital Markets Q2 2021 Deal Highlights International Capital Markets Q1 2021 Deal Highlights
International Capital Markets & Deal Highlights 2020 International Capital Markets Q2 2020 Deal Highlights
International Capital Markets Q1 2020 Deal Highlights International Capital Markets & Deal Highlights 2019
August 2024 Bird & Bird's Summer 2024 PLC Update
June 2023: Bird & Bird's Summer 2023 PLC Update
November 2022: Secondary Capital Raising Review Recommendations
April 2022: UK Prospectus Regime Changes
April 2022: Proposed Changes to the UK Financial Promotion Regime
April 2022: Hybrid and Virtual General Meetings
April 2022: Power to block listings on National Security Grounds
April 2021: Review of UK Listing Regime
April 2021: Medicinal Cannabis Companies begin to list on London Stock Exchange
April 2021: New Climate related Disclosure Requirements for Listed Companies
April 2021: New major shareholdings notification portal announced
April 2021: Proposed new UK foreign investment and listing restrictions
December 2019: New ESMA Guidelines on Risk Factors in Prospectuses come into force
December 2019: Shareholders' Rights Directive II – implications for Listed Companies
December 2019: QCA Publish Updated Audit Committee Guide
December 2019: FCA review of unbundling of research costs under MiFID II
June 2019: New Prospectus Regulation – Final Implementation
June 2019: FCA Competition Enforcement